ArticleThe Journal of clinical investigation2020

Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host disease.

Bishwas Shrestha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.